To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe

NACompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

June 11, 2021

Study Completion Date

December 7, 2021

Conditions
Osteoarthritis (OA) of the Knee
Interventions
DEVICE

Hyruan ONE®

For use as a symptomatic treatment of osteoarthritis (OA) of the knee

DEVICE

Durolane®

For use as a symptomatic treatment of osteoarthritis (OA) of the knee

Trial Locations (1)

21-040

Lubelskie Centrum Diagnostyczne, Świdnik

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT04732793 - To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe | Biotech Hunter | Biotech Hunter